Gail Hopkins, MD
Orthopaedic Surgery of the Spine · Redlands, CANPI 1346336864
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $626,986 of the $729,704 with a category attached, or 85.9%. Inland Surgical Products, LLC accounts for 85.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $625,984 and has fallen 98.8% since, to $7,805 in 2025.
Across 24 payments — averaging $30,404 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inland Surgical Products, LLC$627K
- Renovis Surgical Technologies, Inc.$51K
- Kyocera Medical Technologies, Inc.$50K
- Johnson & Johnson$480
- Si-bone, Inc.$305
- Zimmer Biomet$143
- plus $185 from 4 others
Across 31 payments — averaging $402.96 each. An ownership or investment interest held by the physician or an immediate family member.
- Midwest Surgical Alliance, LLC$8K
- Central California Surgical Distributors, LLC$2K
- Sequoia Surgical Distributors, LLC$2K
- Alpine Implant Alliance, LLC$0
- Renovis Surgical Technologies, Inc.$0
- North Idaho Surgical Cooperative, LLC$0
What the payments were for
- Royalty or licence$83,41411%
- Consulting fees$18,0002%
- Travel & lodging$3050%
- Food & beverage$9990%
- Ownership interest$626,98686%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inland Surgical Products, LLC | 2 | $626,986 |
| Renovis Surgical Technologies, Inc. | 1 | $51,106 |
| Kyocera Medical Technologies, Inc. | 8 | $50,498 |
| Johnson & Johnson | 7 | $480 |
| Si-bone, Inc. | 1 | $305 |
| Zimmer Biomet | 1 | $143 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| Bioventus LLC | 1 | $27 |
| Medtronic | 1 | $17 |
| Globus Medical | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IFUSE IMPLANT SYSTEM$305
- ZMR$143
- NA$137
- EXPAREL$125
How this compares
$729,704 in reported general payments places this provider in the 85th percentile of 288 orthopaedic surgery of the spine providers in California.
See all orthopaedic surgery of the spine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $298 |
| Meloxicam | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Redlands
- John SteinmannRedlands$1M
- Hyun BaeSanta Monica$56.8M
- Choll KimSan Diego$4M
- Stacey BedermanOrange$3.7M
- Gregory Mundisla Jolla$3.3M
- Paul SlosarDaly City$3.1M
- Babak Barcohanavan Nuys$2.9M
- Neelakantan AnandLos Angeles$2.9M
- Sanjay KhuranaMarina del Rey$2.3M
- Neville AlleyneOceanside$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.